专利检索 ap:("LUPIN LIMITED") AND inv:"Amit Kumar DAS" 第 1 页

1.

发明申请
SULFONAMIDE COMPOUNDS AS VOLTAGE-GATED SODIUM CHANNEL MODULATORS 审中-公开

公开(公告)号：US20180186777A1

公开(公告)日：2018-07-05

申请号：US15757103

申请日：2016-09-03

申请人： LUPIN LIMITED

发明人： Vidya RAMDAS , Rajeshkumar Maganlal LORIYA , Moloy BANERJEE , Pradeep Rangrao PATIL , Advait Arun JOSHI , Laxmikant Shamlal DATRANGE , Deepak Sahebrao WALKE , Talha Hussain KHAN , Amit Kumar DAS , Ganesh Navinchandra GOTE , Vaibhav Madhukar KALHAPURE , Venkata P. PALLE , Rajender Kumar KAMBOJ

IPC分类号： C07D405/12 , C07D405/14 , C07D413/14 , C07D417/14 , A61P29/00

CPC分类号： C07D405/12 , A61P29/00 , C07D405/14 , C07D413/14 , C07D417/14

摘要： The present invention relates to sulfonamide compounds Formula (I) wherein the substituents are as described herein, and their use in a medicine for the treatment of diseases, disorders associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. It further relates to the compounds herein and their pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof useful in treating diseases, disorders, syndromes and/or conditions associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. The invention also relates to process for the preparation of the compounds of the invention.

2.

发明申请
SULFONAMIDE COMPOUNDS AS VOLTAGE GATED SODIUM CHANNEL MODULATORS 审中-公开

公开(公告)号：US20170137415A1

公开(公告)日：2017-05-18

申请号：US15300337

申请日：2015-03-27

申请人： LUPIN LIMITED

发明人： Vidya RAMDAS , Rajeshkumar Maganlal LORIYA , Deepak Sahebrao WALKE , Amit Kumar DAS , Talha Hussain KHAN , Moloy BANERJEE , Venkata P. PALLE , Rajender Kumar KAMBOJ

IPC分类号： C07D417/12 , C07D417/14

CPC分类号： C07D417/12 , C07D417/14

摘要： The present invention relates to the compound of Formula (I) wherein the substituents are as described herein, and their use in a medicine for the treatment of diseases, disorders associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. It further relates to the compounds herein and their pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof useful in treating diseases, disorders, syndromes and/or conditions associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. The invention also relates to process for the preparation of the compounds of the invention.